Vetiselinenol is a sesquiterpene alcohol closely associated with vetiver-root oil profiles and repeatedly used as a composition marker in AromaForge vetiver records. The current evidence base is strong for identity, structure, and recurrent occurrence across Indian, Haitian, and Java-style vetiver oils, but weak for isolated-compound bioactivity or human safety data. The most accurate archive positioning is as a vetiver-character constituent with solid chemistry support and substantial direct-study gaps.
Chemical identity and composition
NIST indexes vetiselinenol as trans-Eudesma-4(15),7-dien-12-ol with formula C15H24O, while PubChem resolves the same constituent under CID 527240. In the vetiver literature, it is often reported as part of sesquiterpene-alcohol-rich marker sets alongside khusimol, isovalencenol, and vetivone isomers; some papers quantify it in co-eluting peaks rather than as a fully isolated single peak, so literature percentages should be treated carefully.
Aroma and practical use
- Use the recorded woody, earthy, dry, vetiver-like descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2012 study of four south Indian vetiver oils listed trans-eudesma-4(15),7-dien-12-ol (vetiselinenol) among the major marker peak groups at 3.7% to 5.9%, supporting its use as a characteristic vetiver composition marker.
A 2012 study of four south Indian vetiver oils listed trans-eudesma-4(15),7-dien-12-ol (vetiselinenol) among the major marker peak groups at 3.7% to 5.9%, supporting its use as a characteristic vetiver composition marker.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A 2014 seasonal vetiver-root study isolated or identified vetiselinenol alongside khusimol, beta-vetivenene, isovalencenol, and vetivones in dichloromethane fractions, but the accessible abstract only attributed slight direct antimicrobial activity to khusimol rather than to vetiselinenol itself.
A 2014 seasonal vetiver-root study isolated or identified vetiselinenol alongside khusimol, beta-vetivenene, isovalencenol, and vetivones in dichloromethane fractions, but the accessible abstract only attributed slight direct antimicrobial activity to khusimol rather than to vetiselinenol itself.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 1970 structure paper established the structures of zizanol and vetiselinenol, which anchors modern vetiver-composition references for this constituent.
A 1970 structure paper established the structures of zizanol and vetiselinenol, which anchors modern vetiver-composition references for this constituent.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
No constituent-specific human safety studies, dermal limits, or modern fragrance-safety monographs were verified for isolated vetiselinenol in the reviewed public sources.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Because direct isolated-compound bioactivity evidence is sparse, archive copy should avoid therapeutic claims for vetiselinenol and keep discussion chemistry-led.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
no constituent specific mechanism verified
No direct molecular target or validated mechanism for isolated vetiselinenol was verified in this research pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- No human clinical studies specific to isolated vetiselinenol were verified.
- No direct constituent-specific mechanism or robust isolated-compound efficacy literature was located.
- Constituent-specific sensitization, inhalation, and topical-limit data remain unclear in public sources.
- No constituent-specific numeric dermal reference is available here.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.